Impedimed

Impedimed Limited is a medical software technology company based in Australia, specializing in the development, manufacture, and distribution of noninvasive bioimpedance spectroscopy (BIS) devices and software services. Its primary products include the SOZO device, designed for detecting lymphedema and monitoring fluid status in heart failure patients, along with the SFB7 device for analyzing body composition in healthy individuals and ImpediVET for veterinary applications. Impedimed's BIS technology is recognized for its accuracy and is the only commercially available BIS in the world, operating across a wide frequency range to capture detailed biometric data. The company serves hospitals and clinics globally, with a significant portion of its revenue generated in North America. In addition to its medical devices, Impedimed offers a cloud-based platform for managing patient data, emphasizing its commitment to advancing healthcare technology. Founded in 1999 and headquartered in Pinkenba, Australia, Impedimed is experiencing substantial growth driven by increasing demand for its innovative product offerings.